Aeolus Pharmaceuticals, Inc.
AOLS
$0.00
$0.000.00%
OTC PK
| 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | 06/30/2016 | |
|---|---|---|---|---|---|
| Net Income | -949.00K | -1.04M | -1.09M | -1.02M | -873.00K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | 12.00K | 0.00 |
| Total Other Non-Cash Items | 29.00K | 27.00K | 27.00K | 21.00K | 34.00K |
| Change in Net Operating Assets | 342.00K | 94.00K | -200.00K | 389.00K | 86.00K |
| Cash from Operations | -578.00K | -914.00K | -1.26M | -601.00K | -753.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 335.00K | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -335.00K | -- |
| Cash from Financing | -- | -- | -- | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -578.00K | -914.00K | -1.26M | -601.00K | -753.00K |